Boffa M - Search Results

1

Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin.

Swearingen CA, Sloan JH, Rhodes GM, Siegel RW, Bivi N, Qian Y, Konrad RJ, Boffa M, Koschinsky M, Krege J, Ruotolo G, Nicholls SJ, Michael LF, Wen Y. Swearingen CA, et al. Among authors: boffa m. J Lipid Res. 2024 Dec 6:100723. doi: 10.1016/j.jlr.2024.100723. Online ahead of print. J Lipid Res. 2024. PMID: 39647781 Free article.

2

Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a).

Scipione CA, Sayegh SE, Romagnuolo R, Tsimikas S, Marcovina SM, Boffa MB, Koschinsky ML. Scipione CA, et al. Among authors: boffa mb. J Lipid Res. 2015 Dec;56(12):2273-85. doi: 10.1194/jlr.M060210. Epub 2015 Oct 16. J Lipid Res. 2015. PMID: 26474593 Free PMC article.

3

Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

Boffa MB, Koschinsky ML. Boffa MB, et al. J Lipid Res. 2016 May;57(5):745-57. doi: 10.1194/jlr.R060582. Epub 2015 Dec 8. J Lipid Res. 2016. PMID: 26647358 Free PMC article. Review.

4

The renaissance of lipoprotein(a): Brave new world for preventive cardiology?

Ellis KL, Boffa MB, Sahebkar A, Koschinsky ML, Watts GF. Ellis KL, et al. Prog Lipid Res. 2017 Oct;68:57-82. doi: 10.1016/j.plipres.2017.09.001. Epub 2017 Sep 6. Prog Lipid Res. 2017. PMID: 28888913 Review.

5

Lipoprotein(a) and cardiovascular disease.

Boffa MB, Koschinsky ML. Boffa MB, et al. Biochem J. 2024 Oct 2;481(19):1277-1296. doi: 10.1042/BCJ20240037. Biochem J. 2024. PMID: 39302109 Free PMC article. Review.

6

Screening for and management of elevated Lp(a).

Boffa MB, Koschinsky ML. Boffa MB, et al. Curr Cardiol Rep. 2013 Nov;15(11):417. doi: 10.1007/s11886-013-0417-8. Curr Cardiol Rep. 2013. PMID: 24057771 Review.

7

Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a).

Romagnuolo R, Marcovina SM, Boffa MB, Koschinsky ML. Romagnuolo R, et al. Among authors: boffa mb. J Lipid Res. 2014 Apr;55(4):625-34. doi: 10.1194/jlr.M036566. Epub 2014 Jan 29. J Lipid Res. 2014. PMID: 24478033 Free PMC article.

8

The journey towards understanding lipoprotein(a) and cardiovascular disease risk: are we there yet?

Boffa MB, Koschinsky ML. Boffa MB, et al. Curr Opin Lipidol. 2018 Jun;29(3):259-267. doi: 10.1097/MOL.0000000000000499. Curr Opin Lipidol. 2018. PMID: 29528858 Review.

9

Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease.

Boffa MB, Koschinsky ML. Boffa MB, et al. Nat Rev Cardiol. 2019 May;16(5):305-318. doi: 10.1038/s41569-018-0153-2. Nat Rev Cardiol. 2019. PMID: 30675027 Review.

10

New Frontiers in Lp(a)-Targeted Therapies.

Borrelli MJ, Youssef A, Boffa MB, Koschinsky ML. Borrelli MJ, et al. Trends Pharmacol Sci. 2019 Mar;40(3):212-225. doi: 10.1016/j.tips.2019.01.004. Epub 2019 Feb 4. Trends Pharmacol Sci. 2019. PMID: 30732864 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters